Other languages Daiichi Sankyo Co., Ltd.

Equities

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
5,010 ^JPY	+5.12%		+8.07%	+29.39%

Apr. 25	Scholz pledges further support for the pharmaceutical industry	DP
Apr. 25	Daiichi Sankyo's Attributable Profit Soars 84% in Fiscal 2024	MT

Scholz sichert Pharmabranche weiter Unterstützung zu	Apr. 25
Scholz verspricht Pharma-Branche bei Merck weitere Unterstützung	Apr. 25
Daiichi Sankyo's Attributable Profit Soars 84% in Fiscal 2024	Apr. 25
AstraZeneca upbeat as cancer drugs underpin sales growth	Apr. 25
Le marché devient un peu timbré	Apr. 25
En Direct des Marchés : Hermès, Schneider, Atos, Carrefour, Casino, Sanofi, STMicro, Meta...	Apr. 25
Daiichi Sankyo Company, Limited announces an Equity Buyback for 55,000,000 shares, representing 2.87% for ¥200,000 million.	Apr. 25
Daiichi Sankyo Company, Limited authorizes a Buyback Plan.	Apr. 24
Pharmabranche erwartet Aufschwung - Standort Deutschland zunehmend gefragt	Apr. 24
Japon: le rejet en mer d'eau de Fukushima interrompu après un incident	Apr. 24
Middle East Tensions Dent Asian Stock Markets	Apr. 19
Roche’s HER2-Low Metastatic Breast Cancer Diagnostic Test Secures CE Mark	Apr. 10
Roche erhält CE-Kennung für erstes Brustkrebs-Begleitdiagnostikum	Apr. 10
Scholz setzt auf weitere Pharma-Investitionen in Deutschland	Apr. 08
AstraZeneca's Enhertu Receives FDA Approval for HER2-Positive Solid Tumor Indication	Apr. 08
AstraZeneca, Daiichi Sankyo Secure Accelerated US FDA Clearance for Cancer Treatment Enhertu	Apr. 08
AstraZeneca : approbation étendue pour Enhertu aux USA	Apr. 08
AstraZeneca hails neurological data for Ultomiris, Soliris	Apr. 08
AstraZeneca, Daiichi Sankyo's Solid Tumor Drug Wins US FDA's Accelerated Approval	Apr. 08
Astra hails neurology data; CVS flags cyberattack	Apr. 08

No results for this search